UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis

Sabanovic, Hana; Pauling, John D; Baron, Murray; Clemens, Laurence; Del Galdo, Francesco; Denton, Christopher P; Distler, Oliver; ... Ross, Laura; + view all (2025) 'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis. Rheumatology , Article keaf377. 10.1093/rheumatology/keaf377. (In press). Green open access

[thumbnail of keaf377.pdf]
Preview
Text
keaf377.pdf

Download (785kB) | Preview

Abstract

OBJECTIVES: Physician global assessments (PhyGAs) are commonly performed in randomised controlled trials (RCTs) in systemic sclerosis (SSc). However, there is no single PhyGA applied across RCTs. We performed an exploratory qualitative study to explore perceptions of the PhyGA, its role in RCTs and how physicians perform their own assessment. METHODS: Participants with expertise in the clinical assessment and research of SSc were invited to participate. Participants were asked to define disease constructs of activity, damage, severity and overall health, how they perform a PhyGA and their perception of what a PhyGA should assess. Interview transcripts were analysed using deductive and inductive thematic analysis. RESULTS: Eighteen rheumatologists and one patient research partner were interviewed. Four major themes were identified: i) Physician uncertainty; ii) Variation in the conduct of a PhyGA; iii) Physician efforts to improve PhyGA consistency; iv) Utility of a PhyGA. Most participants felt a PhyGA should assess changeable aspects of SSc, commonly conceived of as disease activity. There was considerable uncertainty about the optimal method to identify disease activity. Participants were uncertain about their own methods of performing a PhyGA and variability in the application of the instrument was identified. Despite these limitations, physicians generally agreed the PhyGA is useful and can assess unquantifiable aspects of SSc. CONCLUSION: We identified significant heterogeneity in the approach to PhyGAs in SSc. This variation was considered a limitation of the PhyGA. Overall, a PhyGA was viewed as a useful instrument that can aid the assessment of treatment response in RCTs.

Type: Article
Title: 'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/rheumatology/keaf377
Publisher version: https://doi.org/10.1093/rheumatology/keaf377
Language: English
Additional information: Copyright © The Author(s) 2025. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Systemic sclerosis, clinical trials, global assessment, outcome measures, physician assessment
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10211657
Downloads since deposit
4Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item